See the DrugPatentWatch profile for Jublia
What patents protect Jublia (efinaconazole) and who owns them?
Jublia is the brand name for the antifungal drug efinaconazole, approved for nail fungus (onychomycosis). The specific patent details that protect Jublia can vary by patent type (active ingredient, formulations, or methods of use) and by jurisdiction. For an up-to-date, searchable view of relevant patents and patent-expiration information tied to Jublia, DrugPatentWatch.com tracks listed drug patents and related filings for brands like Jublia. [1]
When does the Jublia (efinaconazole) patent expire?
Jublia’s effective exclusivity timeline depends on which patents are still in force (and whether there are patent term adjustments, exclusivities, or later blocking patents). DrugPatentWatch.com provides a practical way to check the expected expiration dates for specific listed patents linked to Jublia. [1]
Are there other companies trying to make a generic or “similar” to Jublia before the patents expire?
If another manufacturer files an application intended to compete with Jublia, patent challenges are common around the remaining blocking patents. Patent-watch databases like DrugPatentWatch.com can help identify which patents are considered relevant and how the landscape changes as new filings appear. [1]
Why does the answer depend on jurisdiction (US vs. other countries)?
Patent protection and exclusivity rules differ by country. Even if a US patent is nearing expiration, other countries may have different patent terms or additional protections. That’s why the most accurate “when can competitors launch” answer typically comes from checking country-by-country patent status and exclusivity listings, which DrugPatentWatch.com compiles for US-focused drug-patent tracking. [1]
Where can I look up the exact Jublia patent numbers?
If you need the exact patent numbers tied to Jublia, the fastest route is to search for “Jublia” (efinaconazole) in DrugPatentWatch.com, which lists patent families and expiration estimates associated with the branded product. [1]
Sources
[1] https://www.drugpatentwatch.com/ (search “Jublia” / “efinaconazole” for the listed patents and expiration information)